Urgent

Von Willebrand disease

Inherited bleeding disorder · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Von Willebrand disease (VWD) is the commonest inherited bleeding disorder. Von Willebrand factor (VWF) does two jobs — it mediates platelet adhesion to injured vessel wall, and it carries and stabilises factor VIII — so a deficiency causes a MUCOCUTANEOUS, platelet-type bleeding pattern: easy bruising, prolonged epistaxis, gum bleeding, HEAVY MENSTRUAL bleeding (menorrhagia), and bleeding after dental work, surgery or childbirth. Type 1 (partial quantitative deficiency, commonest and usually mild), Type 2 (qualitative/functional defects — subtypes 2A/2B/2M/2N), and Type 3 (near-complete deficiency — the most severe, with very low factor VIII and even joint/muscle bleeding resembling haemophilia). Distinguish it from the DEEP bleeding of haemophilia and from acquired von Willebrand syndrome.

Red flags

  • Major or uncontrolled bleeding, or bleeding in type 3 disease
  • Bleeding around surgery, dental extraction or childbirth
  • Severe menorrhagia with anaemia
  • Intracranial or GI bleeding

Assessment

Differential diagnosis

  • Haemophilia A/B (deep joint/muscle bleeding; X-linked, male)
  • Platelet function disorders / thrombocytopenia
  • Acquired von Willebrand syndrome (later onset, no family history, associated condition)
  • Connective tissue / vascular causes of easy bruising

Investigations

  • Screening coagulation (PT usually normal; APTT may be prolonged if factor VIII is low) and platelet count/FBC
  • VWD panel: VWF ANTIGEN (VWF:Ag), VWF ACTIVITY (VWF:GPIbM / ristocetin cofactor VWF:RCo), and FACTOR VIII activity
  • Calculate the VWF activity-to-antigen ratio and add multimer analysis / RIPA to TYPE the disease (1 vs 2 vs 3)
  • Blood group (type O has lower baseline VWF); repeat testing as VWF is raised by stress, pregnancy and inflammation

Management

  • Assess bleeding severity and site; resuscitate and apply local haemostatic measures (pressure, packing) for active bleeding.
  • For minor bleeding/procedures in DESMOPRESSIN-RESPONSIVE type 1: give DDAVP (desmopressin), which releases stored VWF/factor VIII — confirm responsiveness beforehand and avoid in type 2B (can worsen thrombocytopenia) and type 3 (no stores).
  • Add ANTIFIBRINOLYTICS (tranexamic acid) for mucosal bleeding, dental work and menorrhagia; hormonal therapy helps heavy menstrual bleeding.
  • For major bleeding, surgery, type 3, or DDAVP-non-responsive disease: give VWF-CONTAINING CONCENTRATE (VWF/factor VIII concentrate, or recombinant VWF).
  • Involve haematology early; give a management/emergency plan and advise avoidance of antiplatelet drugs and NSAIDs.

Drugs & doses

Desmopressin (DDAVP) — type 1 responders; NOT type 2B (thrombocytopenia) or type 3
Tranexamic acid — mucosal bleeding, dental procedures, menorrhagia
VWF-containing concentrate (plasma-derived VWF/FVIII or recombinant VWF) — major bleeding/surgery/type 3
Avoid aspirin/NSAIDs and other antiplatelet agents

Disposition

Most managed as outpatients with a haematology plan; admit for major bleeding, surgery or peripartum management.

Complications & pitfalls

  • Iron-deficiency anaemia from chronic mucosal/menstrual bleeding
  • Peripartum and surgical haemorrhage
  • Joint bleeding/arthropathy in severe (type 3) disease

Exam pearls

  • VWD = MUCOCUTANEOUS (platelet-type) bleeding — bruising, epistaxis, gum bleeding, menorrhagia; contrast with the deep joint/muscle bleeding of haemophilia.
  • Diagnose with VWF:Ag, VWF activity (VWF:GPIbM/RCo) and factor VIII; use the activity/antigen ratio and multimers to type it.
  • DDAVP works for most type 1 disease but NOT type 3 (no stores) and is hazardous in type 2B — know the type before you treat.
  • Tranexamic acid is a cheap, effective adjunct for mucosal bleeding and menorrhagia; avoid aspirin/NSAIDs.

Suspect VWD in lifelong mucocutaneous bleeding or menorrhagia with a family history: confirm with VWF antigen, VWF activity and factor VIII (then type it). Treat by type — DDAVP for responsive type 1, tranexamic acid for mucosal bleeding/menorrhagia, and VWF-containing concentrate for major bleeding, surgery, type 3 or DDAVP-non-responders — and involve haematology.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.